Showing 1 - 10 of 23
How much does US-based R&D benefit other countries and through what mechanisms? We test the "technology sourcing" hypothesis that foreign research labs located on US soil tap into US R&D spillovers and improve home country productivity. Using panels of UK and US firms matched to patent data we...
Persistent link: https://www.econbiz.de/10010745644
How much does US-based R&D benefit other countries and through what mechanisms? We test the 'technology sourcing' hypothesis that foreign research labs located on US soil tap into US R&D spillovers and improve home country productivity. Using panels of UK and US firms matched to patent data we...
Persistent link: https://www.econbiz.de/10010293047
How much does US-based R&D benefit other countries and through what mechanisms? We test the "technologysourcing" hypothesis that foreign research labs located on US soil tap into US R&D spillovers and improvehome country productivity. Using panels of UK and US firms matched to patent data we...
Persistent link: https://www.econbiz.de/10005797205
How much does US-based R&D benefit other countries and through what mechanisms? We test the ‘technology sourcing’ hypothesis that foreign research labs located on US soil tap into US R&D spillovers and improve home country productivity. Using panels of UK and US firms matched to patent data...
Persistent link: https://www.econbiz.de/10005661780
This paper provides a novel portrait of firms engaging in the international use of inventors. I focus on drug discovery activity of pharmaceutical and biotechnological firms head-quartered in Europe, over the period 1996-2005. An important part of the most high-valued added R&D activities are...
Persistent link: https://www.econbiz.de/10011300269
In this paper, we consider the extent to which R&D outsourcing and centralisation of R&D within the firm varies depending on the products that the firm produces and how applied the R&D is to a particular product. We find that, in general, the most applied type of R&D is more likely to be...
Persistent link: https://www.econbiz.de/10005232498
This paper provides a novel portrait of firms engaging in the international use of inventors. I focus on drug discovery activity of pharmaceutical and biotechnological firms head-quartered in Europe, over the period 1996-2005. An important part of the most high-valued added R&D activities are...
Persistent link: https://www.econbiz.de/10011526729
This paper examines the impact of fiscal incentives on the level of R&D investment. An econometric model of R&D investment is estimated using a new panel of data on tax changes and R&D spending in nine OECD countries over a 19-year period (1979–1997). We find evidence that tax incentives are...
Persistent link: https://www.econbiz.de/10009141750
This paper investigates the economic impact of the government's proposed new UK R&D tax credit. We measure the benefit of the credit by the effect on value added in the short and long_run. This is simulated from existing econometric estimates of the tax_price elasticity of R&D and the effect of...
Persistent link: https://www.econbiz.de/10010928789
Persistent link: https://www.econbiz.de/10010884706